Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078013 · ClinicalTrials.gov registry record · Phase 2
MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients
A Phase 2 study of Myocardial Infarction, sponsored by Tanabe Pharma Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 414
- Enrollment target
- 1
- Study location
NCT00078013: Completed Phase 2 study of Myocardial Infarction, sponsored by Tanabe Pharma Corporation.
NCT00078013 is a Phase 2 study of Myocardial Infarction that has completed, run by Tanabe Pharma Corporation. The registered enrollment target is 414 participants, below the 4,675-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00078013, a Phase 2 study of Myocardial Infarction, has completed, sponsored by Tanabe Pharma Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 414 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The primary objectives of this study are to examine the safety, tolerability, and efficacy of intravenous MCC-135 in limiting final infarct size, as measured by single photon emission computed tomography (SPECT), in patients who require percutaneous coronary intervention (PCI) for a first-documented ST-segment elevation acute myocardial infarction (AMI).
Conditions Studied
Interventions
- DRUG MCC-135
Study Locations (1)
Massachusetts
- Massachusetts General Hospital/ Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 414 participants |
| Start Date | 2003-04 |
| Est. Completion | 2004-08 |
| Phase | Phase 2 |
What the finished NCT00078013 record still lists
NCT00078013 is an interventional study that assigns participants to a tested intervention. The registered 414 participants enrollment target is mid-sized for trials with a published cap, below the 4,675-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which MCC-135 is the first listed.
NCT00078013 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00078013 about?
NCT00078013 is a clinical study titled "MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients". This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The primary objectives of this study are to examine the safety, tolerability, and efficacy of intravenous MCC-135 in limiting final infarct size, as measured by single photon emission computed tomography (SPECT...
What is the current status of trial NCT00078013?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 414 participants. The study started on 2003-04. Estimated completion is 2004-08.
What conditions does trial NCT00078013 study?
This clinical trial studies the following conditions: Myocardial Infarction.
What interventions are being tested in trial NCT00078013?
The interventions under investigation include: MCC-135 (DRUG).
Who is sponsoring clinical trial NCT00078013?
This trial is sponsored by Tanabe Pharma Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078013 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00078013's enrollment target sits among peer trials
414 30th of 64 higher than 35 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
RECRUITING · Phase 2
-
MRI Evaluation of Chest Pain
COMPLETED · Phase 2
-
At-Home Automated External Defibrillator (AED) Training Study
COMPLETED · Phase 2
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia